Business

AstraZeneca board rejects sweetened takeover offer from Pfizer

By Washington Examiner
Published May 2, 2014 9:56am ET
Add Washington Examiner on Google

LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Mergers and Acquisitions Pfizer Pharmaceutical Industry